Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Scott Aaronson

Psychiatry Baltimore, MD Medical Doctor

NPI 1376610790 CMS profile 289492

6501 N Charles St, Baltimore, MD 21204

Open in the dashboard

General payments

$334,437

203 records reported · program years 2019–2025

Research payments

$4,275

Paid to them · 2 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$945,225 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Scott Aaronson of Baltimore, MD is reported in the CMS Open Payments database as having received $334,437 across 203 general payments and $4,275 in research payments paid to them. Separately, studies naming them as principal investigator received $945,225 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Psychiatry profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $92,064 36
2024 General $53,080 42
2023 General $16,950 11
2022 General $17,063 9
2021 General $25,356 12
2020 General $55,959 29
2020 Research $4,275 2
2019 General $73,964 64

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Scott Aaronson
  • Psychiatry median
  • Middle half of Psychiatry
  • National median

In program year 2025, general payments to Scott Aaronson were reported at $92,064. Among 14,155 Psychiatry profiles paid that year, the median was $180 and the middle half received between $58 and $685.

Show as a table
Year Scott Aaronson Psychiatry median Middle half National median
2019 $73,964 $184 $59–$605 $163
2020 $55,959 $119 $36–$372 $114
2021 $25,356 $143 $43–$576 $132
2022 $17,063 $153 $50–$590 $149
2023 $16,950 $170 $56–$651 $160
2024 $53,080 $179 $57–$673 $164
2025 $92,064 $180 $58–$685 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. LivaNova USA, Inc. $245,267 115 payments
  2. Janssen Pharmaceuticals, Inc $43,216 51 payments
  3. Neuronetics, Inc. $32,915 12 payments
  4. Sunovion Pharmaceuticals Inc. $5,182 6 payments
  5. Sage Therapeutics, Inc. $5,128 10 payments
  6. Boehringer Ingelheim Pharmaceuticals, Inc. $2,546 6 payments
  7. Neurocrine Biosciences, Inc. $116 1 payment
  8. Zap Surgical Systems, Inc. $47 1 payment
  9. AbbVie, Inc. $21 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $188,856 85 payments
  2. Consulting Fee $111,258 28 payments
  3. Travel and Lodging $17,202 30 payments
  4. Honoraria $9,000 1 payment
  5. Food and Beverage $4,821 58 payments
  6. Education $3,300 1 payment
Products named General payments · program years 2019–2025
  1. VNS THERAPY SYMMETRY MODEL 8103 GENERATOR Neurology $137,090 62 payments
  2. VNS Therapy $64,355 29 payments
  3. SPRAVATO $43,216 51 payments
  4. VNS Therapy Symmetry Model 8103 Generator Cardiology/Vascular Diseases $27,847 15 payments
  5. NEUROSTAR TMS THERAPY NeuroStar TMS Therapy $14,490 4 payments
  6. VNS - Symmetry $12,349 4 payments
  7. NEUROSTAR TMS THERAPY NeuroStar TMS Therapy $10,800 1 payment
  8. Neurostar TMS Therapy System $7,625 7 payments
  9. LATUDA $5,182 6 payments
  10. VNS THERAPY SENTIVA MODEL 1000 GENERATOR $2,700 3 payments
  11. Other $1,249 8 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Neuronetics, Inc. $4,275 2 payments

Records

205 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Psychiatry in Maryland

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record